|
5-year local-regional control
|
p- value*
|
5-year overall survival
|
p- value*
|
---|
Age in years
| | | | |
Continuous variable
| |
.136
| |
<.001
|
Sex
| |
.896
| |
.438
|
Male
|
87%
| |
79%
| |
Female
|
87%
| |
77%
| |
Race
| |
.091
| |
.261
|
White
|
88%
| |
81%
| |
Non-white
|
76%
| |
62%
| |
Smoke
| |
.002
| |
<.001
|
Current
|
75%
| |
60%
| |
Former
|
88%
| |
80%
| |
Never
|
92%
| |
88%
| |
Primary site
| |
.006
| |
<.001
|
Tonsil
|
91%
| |
83%
| |
Base of tongue
|
86%
| |
80%
| |
Other
|
65%
| |
43%
| |
T-category
| |
<.001
| |
<.001
|
1-2
|
94%
| |
90%
| |
3-4
|
75%
| |
60%
| |
N-category
| |
.446
| |
.001
|
0
|
74%
| |
65%
| |
1 -2a
|
93%
| |
86%
| |
2b – 2c
|
86%
| |
79%
| |
3
|
80%
| |
59%
| |
Lowest neck level
| |
.529
| |
.498
|
0
|
74%
| |
67%
| |
2
|
90%
| |
83%
| |
3
|
86%
| |
77%
| |
4
|
76%
| |
67%
| |
Treatment
| |
.454
| |
.027
|
XRT alone
|
92%
| |
86%
| |
CTXRT
|
82%
| |
72%
| |
Ind. CTX > XRT
|
89%
| |
84%
| |
Ind. CTX > CTXRT
|
81%
| |
71%
| |
Radiation technique
| |
.003
| |
.084
|
IMRT
|
92%
| |
84%
| |
3D conformal
|
77%
| |
66%
| |
Radiation Fractionation
| |
.414
| |
.150
|
Once- daily
|
90%
| |
83%
| |
Altered fractionation
|
81%
| |
70%
| |
- *multivariable analysis; XRT – Radiotherapy; CTXRT – concurrent chemoradiation; Ind. CTX – Induction chemotherapy.